ArticleCellular oncology (Dordrecht, Netherlands)2024

IRE1α inhibitor reduces cisplatin resistance in ovarian cancer by modulating IRE1α/XBP1 pathway.

Shiyi Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.